Cancer trials: money is not only currency of success
Alan Maynard's article ('Looking Askance', 19 November), on the cost-effectiveness of cancer services, was disappointing in its narrowness of approach.
You need to be an HSJ subscriber to read more
Subscribe to read the full article
With an HSJ subscription you’ll get access to:
- Expert Briefing newsletters, covering nine topics and regions
- Weekly Catch Up – a summary of the week’s most important stories
- Unlimited access to hsj.co.uk
- The HSJ app
Enquire about multi-user access